Videos

Hans
Gerstmans
FWO
KU Leuven
UGent

Enzybiotics in drops: a killer combination!

Almost 100 years ago Alexander Fleming discovered the first antibiotic: penicillin. Even then, he warned that there would come a day when bacteria would be resistant to all antibiotics. That day is now very near. Will the 'killer combination' of enzybiotics and water droplets save us from super-bacteria?
Laure
Sorber
UAntwerpen

Blood as a messenger in the fight against cancer

A cancer patient's blood contains valuable information about the cancer tumor, which can help determine the best treatment. However, in order to extract that information properly from the blood in the laboratory, the blood samples need to be treated carefully. Laure Sorber developed a manual for this.
Charysse
Vandendriessche
UGent
VIB

Fewer calories as a weapon against Alzheimer's disease?

Mice that follow a low-calorie diet appear to be protected against the development of Alzheimer’s disease. Charysse Vandendriessche is investigating why this is the case to gather more insight in the underlying disease mechanism. This information could into the future contribute to the development of a treatment against this devastating disease.

Rahel
Park
KU Leuven
VIB

Who is hitching a ride on a housefly?

Rahel Park has a dilemma for you: what to do if a bunch of flies land on the cake you were just about to eat? Should you eat it anyway or should you throw it away? Watch the video for the -scientifically substantiated- answer!
Arnout
Bruggeman
UGent
VIB

How do intestinal bacteria affect Parkinson's disease?

Imagine if you could influence Parkinson's disease by altering the intestinal bacteria of patients? That sounds strange at first glance, but Arnout Bruggeman explains why it might work.
Sebastian
Proost
KU Leuven
VIB

Bytes and bacteria: software to explore the intestinal flora

What happens when you as thousands of Flemish people to send samples of their stools for scientific research? Well, you get this huge pile of... right, data. Sebastian Proost makes this data readily available to doctors and scientists so that they can acquire new insights from this data in an efficient manner.
Marlies
Vanden Bempt
KU Leuven
VIB

Immunotherapy: why screening patients is key

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why.
Matteo
Rossi
FWO
KU Leuven
VIB

Finding the weak spot of breast cancer cells

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.
Alice
Cavolo
FWO
KU Leuven

How far can we go to save extremely premature babies?

Extremely premature babies often need to be resuscitated at birth. While this might help them to survive, they will sometimes live on with severe disabilities. Is resuscitation therefore always in the best interest of the babies? Alice Cavolo wants to help parents and physicians in making this extremely difficult decision.
Ben
Somers
FWO
KU Leuven

How can we make hearing implants smarter?

A cochlear implant makes it possible for the deaf and hearing impaired to hear well. This is a wonderful invention, but it requires some work to properly set up and keep the device up to date. But Ben Somers has a solution for that!
Jolien
Robijns
UHasselt

Can light therapy prevent burns?

Many cancer patients undergo radiotherapy as a treatment. Unfortunately, due to this treatment they often suffer from painful burns. Jolien Robijns (Hasselt University International) tries to prevent these burns. How? By using laser light.
Elien
Derveaux
UHasselt

How lung cancer leaves useful traces in the blood

Every year about 8,000 people in Belgium develop lung cancer. These people may get the same diagnosis, but their bodies react differently. Elien Derveaux (Universiteit Hasselt) examines whether, on the basis of these differences, we can predict which treatment is most suitable for the patient.